ArQule Announces Initiation Of Clinical Programs With ARQ 197 In Germ Cell Tumors And Colorectal Cancer
Links shared publicly online about this topic.
- 1,399total visits
ArQule Announces Initiation Of Clinical Programs With ARQ 197 In Germ Cell Tumors And Colorectal Cancer
ArQule, Inc. (Nasdaq: ARQL) announced the initiation of a Phase 2, single agent trial with ARQ 197 in germ cell tumors (GCT), including testicular and non-central nervous system (non-CNS) tumors, and a Phase 1/2 clinical trial designed to evaluate th
View full resource at tweetmeme.com
Tags: Nervous System, Cancer, Rectal Cancer, Colon Cancer, Clinical Trial, Men's Health
Most Recently Shared on February 7, 2010 at 12:49 pm By:
ArQule Announces Initiation Of Clinical Programs With ARQ 197 In Germ Cell Tumors And Colorectal ... http://ow.ly/1of9jf (via @healthytweet)
Advertisement
